We recently had the pleasure of hosting the “EU Pharma Launch and Brexit: Unanticipated Challenges” event at MassBio in Boston. This gathering brought together industry experts, pharma professionals, and various stakeholders to explore the multifaceted impact of Brexit on EU pharmaceutical product launches. 

Exploring Crucial Areas 

The event delved deeply into several critical areas affected by Brexit: 

  • Entity Structure: Understanding the implications for company structures and legal entities operating within the EU. 
  • Licensing: Addressing changes in licensing requirements and processes post-Brexit. 
  • Customs: Navigating the new customs regulations and their impact on the pharma supply chain. 
  • Finance: Examining the financial aspects, including tariffs, taxes, and funding challenges. 

Expert Insights and Discussions 

Our distinguished speakers provided invaluable insights into these complex issues, helping attendees to grasp the full scope of Brexit’s impact on their operations. The presentations were followed by engaging discussions, where participants had the opportunity to ask questions and share their experiences. 

Networking and Collaboration 

A networking lunch provided a relaxed setting for attendees to connect, share ideas, and discuss potential collaborations. The goal was to equip everyone with the knowledge and strategies needed to navigate post-Brexit changes and make informed decisions for seamless operations in the EU market. 

St. Patrick’s Day Mixer 

To conclude the event, we had a stand at MassBios St. Patrick’s Day Mixer, which offered a festive atmosphere for further networking. Attendees enjoyed refreshments and continued their discussions in a more informal and relaxed setting, fostering stronger connections and community spirit. 

Reflecting on a Successful Event 

Overall, the event was a resounding success. It was a fantastic trip, and we greatly enjoyed the opportunity to connect with everyone who attended. We are committed to supporting the pharmaceutical industry through these challenging times and look forward to hosting more events in the future. 

Stay tuned for more updates and insights from Orphan Drug Consulting. 

Leave a reply